Cargando…

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens

BACKGROUND: The distinction of lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has important therapeutic implications. Napsin A is a recently developed marker, which has shown high specificity for lung tissue in the surgical pathology specimens. In this study, we have evaluated whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Seema, Geng, Lili, Shidham, Vinod B, Archuletta, Pamela, Bandyophadhyay, Sudeshna, Feng, Jining, Madan, Shashi, Shi, Dongping, Tranchida, Paul, Giorgadze, Tamar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347720/
https://www.ncbi.nlm.nih.gov/pubmed/22582081
http://dx.doi.org/10.4103/1742-6413.94570
_version_ 1782232316361310208
author Sethi, Seema
Geng, Lili
Shidham, Vinod B
Archuletta, Pamela
Bandyophadhyay, Sudeshna
Feng, Jining
Madan, Shashi
Shi, Dongping
Tranchida, Paul
Giorgadze, Tamar
author_facet Sethi, Seema
Geng, Lili
Shidham, Vinod B
Archuletta, Pamela
Bandyophadhyay, Sudeshna
Feng, Jining
Madan, Shashi
Shi, Dongping
Tranchida, Paul
Giorgadze, Tamar
author_sort Sethi, Seema
collection PubMed
description BACKGROUND: The distinction of lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has important therapeutic implications. Napsin A is a recently developed marker, which has shown high specificity for lung tissue in the surgical pathology specimens. In this study, we have evaluated whether the use of a panel of novel multiplex cocktails of TTF-1 + Napsin A and p63 + CK5 for dual color immunostaining will improve the diagnostic accuracy of lung adenocarcinoma and squamous cell carcinoma in fine needle aspiration (FNA) specimens, usually with relatively scant microfragments of diagnostic material. MATERIALS AND METHODS: Formalin-fixed, paraffin-embedded, adequately cellular FNA cell blocks with a confirmed diagnosis of either ADC (n = 22), SCC (n = 20) or poorly differentiated carcinoma (PDC; n = 7), from a total of 49 consecutive cases, were studied. All these cases had subsequently confirmed diagnosis in biopsies or resection specimens. The sections were immunostained with two color methods of TTF-1 + Napsin A and p63 + CK5 multiplex cocktails. The presence of one or more unequivocal individual tumor cells with convincing brown nuclear TTF-1 and red cytoplasmic Napsin A staining, and cells with brown nuclear p63 and membranous / cytoplasmic CK5 staining were interpreted as ‘positive’. RESULTS: All 20 FNA cell blocks from SCC cases were positive for dual stain p63 + CK5 and negative for dual stain TTF-1 + Napsin A. The sensitivity and specificity of the dual immunoexpressions of p63 + CK5 for SCC of lung FNAs were both 100%. All 22 ADC cases were positive with dual stain of TTF-1 + Napsin A and negative for dual stain of p63 + CK5. On follow-up of the surgical pathology specimens, 22 cases were confirmed as ADC. The sensitivity of the dual immunoexpression of TTF-1 + Napsin A for ADC of lung FNAs was 100% and the specificity was also 100%. Of the seven PDC cases, five cases that were positive for dual stain p63 + CK5 and negative for dual stain TTF-1 + Napsin A could be categorized as SCC. Two of the seven (2 / 7) PDC cases were positive for dual stain TTF-1 + Napsin A and negative for dual stain p63 + CK5, consistent with ADC. CONCLUSIONS: Simultaneous coordinate or individual immunostaining for Napsin A / TTF-1 in ADC and p63 / CK5 in SCC demonstrated high sensitivity and specificity. The panel with multiplex Napsin A / TTF-1 and p63 / CK5 dual color immunostains could specifically subcategorize PDC into ADC and SCC in lung FNA specimens. Multiplex dual color Napsin A / TTF-1 and p63 / CK5 immunostaining is especially recommended for evaluation of FNA specimens with relatively scant cellularity.
format Online
Article
Text
id pubmed-3347720
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33477202012-05-11 Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens Sethi, Seema Geng, Lili Shidham, Vinod B Archuletta, Pamela Bandyophadhyay, Sudeshna Feng, Jining Madan, Shashi Shi, Dongping Tranchida, Paul Giorgadze, Tamar Cytojournal Research Article BACKGROUND: The distinction of lung adenocarcinoma (ADC) from squamous cell carcinoma (SCC) has important therapeutic implications. Napsin A is a recently developed marker, which has shown high specificity for lung tissue in the surgical pathology specimens. In this study, we have evaluated whether the use of a panel of novel multiplex cocktails of TTF-1 + Napsin A and p63 + CK5 for dual color immunostaining will improve the diagnostic accuracy of lung adenocarcinoma and squamous cell carcinoma in fine needle aspiration (FNA) specimens, usually with relatively scant microfragments of diagnostic material. MATERIALS AND METHODS: Formalin-fixed, paraffin-embedded, adequately cellular FNA cell blocks with a confirmed diagnosis of either ADC (n = 22), SCC (n = 20) or poorly differentiated carcinoma (PDC; n = 7), from a total of 49 consecutive cases, were studied. All these cases had subsequently confirmed diagnosis in biopsies or resection specimens. The sections were immunostained with two color methods of TTF-1 + Napsin A and p63 + CK5 multiplex cocktails. The presence of one or more unequivocal individual tumor cells with convincing brown nuclear TTF-1 and red cytoplasmic Napsin A staining, and cells with brown nuclear p63 and membranous / cytoplasmic CK5 staining were interpreted as ‘positive’. RESULTS: All 20 FNA cell blocks from SCC cases were positive for dual stain p63 + CK5 and negative for dual stain TTF-1 + Napsin A. The sensitivity and specificity of the dual immunoexpressions of p63 + CK5 for SCC of lung FNAs were both 100%. All 22 ADC cases were positive with dual stain of TTF-1 + Napsin A and negative for dual stain of p63 + CK5. On follow-up of the surgical pathology specimens, 22 cases were confirmed as ADC. The sensitivity of the dual immunoexpression of TTF-1 + Napsin A for ADC of lung FNAs was 100% and the specificity was also 100%. Of the seven PDC cases, five cases that were positive for dual stain p63 + CK5 and negative for dual stain TTF-1 + Napsin A could be categorized as SCC. Two of the seven (2 / 7) PDC cases were positive for dual stain TTF-1 + Napsin A and negative for dual stain p63 + CK5, consistent with ADC. CONCLUSIONS: Simultaneous coordinate or individual immunostaining for Napsin A / TTF-1 in ADC and p63 / CK5 in SCC demonstrated high sensitivity and specificity. The panel with multiplex Napsin A / TTF-1 and p63 / CK5 dual color immunostains could specifically subcategorize PDC into ADC and SCC in lung FNA specimens. Multiplex dual color Napsin A / TTF-1 and p63 / CK5 immunostaining is especially recommended for evaluation of FNA specimens with relatively scant cellularity. Medknow Publications & Media Pvt Ltd 2012-03-31 /pmc/articles/PMC3347720/ /pubmed/22582081 http://dx.doi.org/10.4103/1742-6413.94570 Text en Copyright: © 2012 Sethi et al.; licensee Cytopathology Foundation Inc http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sethi, Seema
Geng, Lili
Shidham, Vinod B
Archuletta, Pamela
Bandyophadhyay, Sudeshna
Feng, Jining
Madan, Shashi
Shi, Dongping
Tranchida, Paul
Giorgadze, Tamar
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title_full Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title_fullStr Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title_full_unstemmed Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title_short Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
title_sort dual color multiplex ttf-1 + napsin a and p63 + ck5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347720/
https://www.ncbi.nlm.nih.gov/pubmed/22582081
http://dx.doi.org/10.4103/1742-6413.94570
work_keys_str_mv AT sethiseema dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT genglili dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT shidhamvinodb dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT archulettapamela dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT bandyophadhyaysudeshna dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT fengjining dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT madanshashi dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT shidongping dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT tranchidapaul dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens
AT giorgadzetamar dualcolormultiplexttf1napsinaandp63ck5immunostainingforsubcategorizingofpoorlydifferentiatedpulmonarynonsmallcarcinomasintoadenocarcinomaandsquamouscellcarcinomainfineneedleaspirationspecimens